Lau Associates’s Zimmer Biomet ZBH Stock Holding History

Lau Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$1.24M	Hold	8,549	–	–	0.62%	40
2019 Q3	$1.14M	Sell	8,549 -2,678	-24%	-$346K	0.6%	46
2019 Q2	$1.28M	Hold	11,227	–	–	0.61%	43
2019 Q1	$1.39M	Sell	11,227 -567	-5%	-$64.4K	0.72%	39
2018 Q4	$1.19M	Sell	11,794 -206	-2%	-$23.2K	0.66%	43
2018 Q3	$1.53M	Hold	12,000	–	–	0.87%	38
2018 Q2	$1.3M	Hold	12,000	–	–	0.89%	40
2018 Q1	$1.27M	Hold	12,000	–	–	0.99%	40
2017 Q4	$1.41M	Buy	12,000 +52	+0.4%	+$5.88K	1.09%	35
2017 Q3	$1.36M	Hold	11,948	–	–	1.05%	33
2017 Q2	$1.49M	Buy	11,948 +103	+0.9%	+$12.2K	1.19%	26
2017 Q1	$1.4M	Hold	11,845	–	–	1.26%	26
2016 Q4	$1.19M	Buy	11,845 +412	+4%	+$44.2K	1.2%	31
2016 Q3	$1.44M	Hold	11,433	–	–	1.47%	21
2016 Q2	$1.34M	Sell	11,433 -515	-4%	-$58.3K	1.41%	22
2016 Q1	$1.24M	Buy	+11,948	New	+$1.16M	1.28%	30

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Lau Associates's ZBH Position: Q4 2019 in Review

Lau Associates held its Zimmer Biomet (ZBH) position steady in Q4 2019 at 8,549 shares worth $1.24M. The position accounts for 0.62% of the portfolio, ranked #40.

Lau Associates first reported a position in ZBH in Q1 2016 and has held it in 16 quarters since. The position peaked at $1.53M in Q3 2018. 989 funds tracked by Wall St. Rank hold ZBH as of Q4 2019.

Lau Associates held 8,549 shares of Zimmer Biomet worth $1.24M as of Q4 2019.
Lau Associates left its Zimmer Biomet share count unchanged in Q4 2019.
Zimmer Biomet made up 0.62% of Lau Associates's portfolio in Q4 2019, its #40 holding.
Lau Associates first reported a position in Zimmer Biomet in Q1 2016 and has held it in 16 quarters since.
Lau Associates's Zimmer Biomet position peaked at $1.53M in Q3 2018.
989 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2019.

Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.